4.7 Review

Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

TIPS placement as the first-line therapy to prevent variceal rebleeding in patients with cirrhosis and sarcopenia

Bin Xiong et al.

Summary: Sarcopenia, or muscle wasting, in cirrhosis patients does not increase the risk of post-TIPS mortality and overt HE for those treated with TIPS as the first-line treatment for prevention of rebleeding.

EUROPEAN JOURNAL OF RADIOLOGY (2023)

Article Biochemistry & Molecular Biology

Branched Chain Amino Acids Are Associated with Physical Performance in Patients with End-Stage Liver Disease

Maria Camila Trillos-Almanza et al.

Summary: Decreased circulating BCAA levels in end-stage liver disease (ESLD) patients are associated with disease severity and impaired muscle function. These findings suggest that BCAA may serve as a useful prognostic marker for assessing liver disease severity.

BIOMOLECULES (2023)

Review Geriatrics & Gerontology

An update on cognitive frailty: Its definition, impact, associated factors and underlying mechanisms, and interventions

Taiki Sugimoto et al.

Summary: Cognitive frailty, characterized by the simultaneous presence of physical frailty and cognitive impairment without dementia, requires comprehensive assessment and multimodal personalized interventions to prevent adverse health outcomes. Research suggests that cognitive frailty is associated with social factors, nutritional status, and functional status, requiring further studies to clarify its underlying mechanisms and interactions.

GERIATRICS & GERONTOLOGY INTERNATIONAL (2022)

Review Nutrition & Dietetics

Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis

Georgios Konstantis et al.

Summary: Supplementation with BCAA seems to improve significant prognostic factors for patients with cirrhosis, with potential positive impact in mortality.

CLINICAL NUTRITION (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement

Jiacheng Liu et al.

Summary: In this study, changes in skeletal muscle and fat mass in patients with cirrhosis after TIPS were evaluated, and it was found that muscle mass reduction was an important factor associated with mortality.

RADIOLOGY (2022)

Article Medicine, General & Internal

Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome

Anne M. van Dijk et al.

Summary: This study assessed the nutritional status of hepatocellular carcinoma patients using multiple evaluation tools and found that reduced hand-grip strength at baseline and deteriorated Child-Pugh score post-treatment are associated with reduced overall and complication-free survival.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)

Article Nutrition & Dietetics

Impact of Branched Chain Amino Acid on Muscle Mass, Muscle Strength, Physical Performance, Combined Survival, and Maintenance of Liver Function Changes in Laboratory and Prognostic Markers on Sarcopenic Patients With Liver Cirrhosis (BCAAS Study): A Randomized Clinical Trial

Arun Singh Tejavath et al.

Summary: The study demonstrated that long-term BCAAs supplementation improved sarcopenia and prognostic markers in patients with advanced LC, leading to significant improvements in muscle strength, function, and mass, and reducing cirrhotic-related complications and event occurrence rate compared to L-ALB group.

FRONTIERS IN NUTRITION (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Nutrition & Dietetics

Malnutrition in Patients with Liver Cirrhosis

Julia Traub et al.

Summary: Liver cirrhosis is a growing public health threat globally, often accompanied by malnutrition. The underdiagnosis of malnutrition in cirrhosis patients underscores the importance of regular screening, assessment, and interventions by healthcare professionals. Further research is needed to better understand the pathogenic mechanisms and develop targeted therapeutic strategies for malnutrition in cirrhosis.

NUTRIENTS (2021)

Article Gastroenterology & Hepatology

Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial

Marta Hernandez-Conde et al.

Summary: BCAA supplementation improves muscle mass in cirrhotic patients with sarcopenia, and has positive effects on the Liver Frailty Index and zinc levels.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Sarcopenia and frailty in decompensated cirrhosis

Puneeta Tandon et al.

Summary: This review highlights the prevalence of sarcopenia and frailty in patients with decompensated cirrhosis, and emphasizes their association with negative outcomes. The complex pathophysiology underlying these conditions is discussed, along with tools for assessment and management strategies to reverse or prevent their development. Knowledge gaps in measuring muscle mass and function, racial/ethnic variations, and optimal clinical metrics for assessing therapeutic interventions are also identified.

JOURNAL OF HEPATOLOGY (2021)

Review Medicine, General & Internal

Liver cirrhosis

Pere Gines et al.

Summary: Cirrhosis is a widespread disease with various causes, leading to portal hypertension, systemic inflammation, and liver failure. Early diagnosis and management of complications are crucial to prevent progression to decompensated cirrhosis. Liver transplantation may be necessary in severe cases.

LANCET (2021)

Article Gastroenterology & Hepatology

Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis

Sith Siramolpiwat et al.

Summary: Frailty is prevalent in compensated cirrhosis and is associated with the development of decompensation, unplanned hospitalization, and impaired quality of life, providing additional prognostic value beyond recognized risk scores.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Relationship between serum vitamin D level and sarcopenia in chronic liver disease

Tomomi Okubo et al.

HEPATOLOGY RESEARCH (2020)

Article Gastroenterology & Hepatology

Changes in frailty are associated with waitlist mortality in patients with cirrhosis

Jennifer C. Lai et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy

Christopher F. Rose et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on nutrition in chronic liver disease

JOURNAL OF HEPATOLOGY (2019)

Article Nutrition & Dietetics

ESPEN guideline on clinical nutrition in liver disease

Mathias Plauth et al.

CLINICAL NUTRITION (2019)

Review Gastroenterology & Hepatology

Branched-chain amino acids in liver diseases

Kazuto Tajiri et al.

TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis

Atsushi Hiraoka et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Development of a Novel Frailty Index to Predict Mortality in Patients With End-Stage Liver Disease

Jennifer C. Lai et al.

HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years

Antonio Ascione et al.

LIVER INTERNATIONAL (2017)

Article Gastroenterology & Hepatology

Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization

Michael A. Dunn et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Article Surgery

Depression and Frailty in Patients With End-Stage Liver Disease Referred for Transplant Evaluation

D. C. Cron et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2016)

Article Nutrition & Dietetics

Efficacy and Safety of Leucine Supplementation in the Elderly

Michael S. Borack et al.

JOURNAL OF NUTRITION (2016)

Article Geriatrics & Gerontology

Quality of life and physical components linked to sarcopenia: The SarcoPhAge study

C. Beaudart et al.

EXPERIMENTAL GERONTOLOGY (2015)

Article Nutrition & Dietetics

Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma

Motoh Iwasa et al.

JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2015)

Article Nutrition & Dietetics

Sarcopenia impairs prognosis of patients with liver cirrhosis

Tatsunori Hanai et al.

NUTRITION (2015)

Article Gastroenterology & Hepatology

Nutrition and exercise in the management of liver cirrhosis

Nobuyuki Toshikuni et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Gastroenterology & Hepatology

Branched-Chain Amino Acids as Pharmacological Nutrients in Chronic Liver Disease

Takumi Kawaguchi et al.

HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Nutritional status: its influence on the outcome of patients undergoing liver transplantation

Manuela Merli et al.

LIVER INTERNATIONAL (2010)

Article Gastroenterology & Hepatology

Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus

Masahiro Kobayashi et al.

JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Effect of a late evening snack on outpatients with liver cirrhosis

Koji Aoyama et al.

HEPATOLOGY RESEARCH (2007)

Article Gastroenterology & Hepatology

The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis

Yohei Urata et al.

HEPATOLOGY RESEARCH (2007)

Article Nutrition & Dietetics

Aromatic amino acid metabolism during liver failure

Cornelis H. C. Dejong et al.

JOURNAL OF NUTRITION (2007)

Article Nutrition & Dietetics

BCAA-enriched snack improves nutritional state of cirrhosis

Yutaka Nakaya et al.

NUTRITION (2007)

Article Nutrition & Dietetics

Branched-chain amino acids: Enzyme and substrate regulation

JT Brosnan et al.

JOURNAL OF NUTRITION (2006)

Article Gastroenterology & Hepatology

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

Y Muto et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)

Article Nutrition & Dietetics

Branched-chain amino acid supplementation in patients with liver diseases

G Marchesini et al.

JOURNAL OF NUTRITION (2005)

Article Gastroenterology & Hepatology

Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial

RTP Poon et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)

Article Gastroenterology & Hepatology

Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis

S Nishiguchi et al.

HEPATOLOGY RESEARCH (2004)

Article Gastroenterology & Hepatology

Administration of granulated BCAA and quality of life

N Kawamura et al.

HEPATOLOGY RESEARCH (2004)